Ambalal Sarabhai Enterprises (ASE) reported a consolidated net profit of Rs. 822.35 lakhs for Q1, a 2270% increase from Rs. 34.71 lakhs in the same quarter last year. Revenue from operations slightly decreased by 0.88% to Rs. 4,033.88 lakhs. The company's pharmaceuticals segment generated Rs. 2,546.42 lakhs, while electronics contributed Rs. 1,487.46 lakhs. On a standalone basis, profit after tax grew by 1391% to Rs. 690.85 lakhs. ASE's Board of Directors formed a new Pharma Committee to oversee pharmaceutical operations, compliance, and business performance.